US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
To-be Listed
Name
/
Code
Industry Offer Price Lot Size Entry Fee Closing Date
Grey Market Date
Listing Date
Hesai-W
02525.HK
Electrical Components & Equipment N/A 20 4,605.99 2025/09/11 2025/09/15 2025/09/16
160 Health
02656.HK
Health Care Supplies 11.89-14.86 250 3,752.47 2025/09/12 2025/09/16 2025/09/17
Summary
Who We Are

We are an experienced pharmaceutical and healthcare product wholesaler and a leading digital healthcare integrated service provider in China. We provide customers with a wide selection of pharmaceutical and healthcare products, as well as comprehensive digital healthcare and wellness solutions. We offer a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through our online healthcare and wellness service platform, Healthcare 160 Platform, we also provide digital healthcare and wellness solutions, empowering each Platform Participants, primarily including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China’s healthcare and wellness industry.

We provide pharmaceutical and healthcare products to business customers, including regional pharmaceutical trading companies, medical and healthcare institutions, and other pharmaceutical sales platforms, under wholesale model and individual users under retail model. Leveraging our robust supply chain resources and strong order fulfillment capabilities, we identify stable and high-quality suppliers to meet our customers’ specific needs and offer efficient product delivery, generating substantial revenue from product sales. During the Track Record Period, our pharmaceutical and healthcare product sales, particularly through our wholesale model, made a substantial contribution to our revenue, consistently positioning it as the primary revenue stream for us. Revenue generated from sale of pharmaceutical and healthcare products constituted 73.2%, 71.7%, 68.7%, 66.6% and 66.9% of our total revenue in 2022, 2023 and 2024 and for the three months ended March 31, 2024 and 2025, respectively, among which, revenue generated from wholesale of pharmaceutical and healthcare products contributed 57.8%, 66.1%, 64.9%, 59.8% and 64.3% of our total revenue during the same periods.

In providing digital healthcare and wellness solutions, we have developed Healthcare 160 Platform, a service platform that integrates healthcare and wellness services through online and offline channels, effectively connecting medical and healthcare institutions, medical professionals, and individual users. Our platform provides a diverse array of healthcare and wellness services, encompassing both essential medical care and consumer healthcare services.

We employ an effective monetization strategy for our digital healthcare and wellness solutions to generate revenue from various Platform Participants, thereby constituting an important revenue stream for us. Revenue generated from our digital healthcare and wellness solutions constituted 26.8%, 28.3%, 31.3%, 33.4% and 33.1% of our total revenue in 2022, 2023 and 2024 and for the three months ended March 31, 2024 and 2025, respectively. According to Frost & Sullivan, we were the largest digital healthcare and wellness service platform in the digital healthcare integrated service industry in China in 2024, in terms of (i) the number of appointments made through the platform in 2024, (ii) the number of cooperated hospitals as of December 31, 2024, (iii) the number of cooperated Class III hospitals as of December 31, 2024, and (iv) the number of medical professionals connected to the platform as of December 31, 2024.

Our technology-driven healthcare and wellness service platform provides integrated support to Platform Participants and creates benefits across different areas of our operations.

Business customers procure pharmaceutical and healthcare products from us, assured by our commitment to timely delivery, complemented by responsive after-sales support. For medical and healthcare institutions, we provide tailored solutions to digitize their operations, improve their operating efficiency and enhance their brand visibility. Medical professionals benefit from our established online practice platform, supporting online healthcare services, patient management, and personal brand promotion. Individual users have easy access to online healthcare services as well as pharmaceutical and healthcare products through our online healthcare and wellness service portal. Our wide-ranging product and service offerings cover from pre-consultation to post-treatment stages, providing both essential medical care and consumer healthcare services to meet diverse needs of individual users. In addition to our services and products for key Platform Participants, we also operate an online marketplace for third-party merchants.

Each business line contributes to the overall development of our platform and supports our growth in its respective area. In the realm of our digital healthcare and wellness solutions, online marketing solutions, together with digital hospital solutions, play a pivotal role in augmenting the platform’s medical resources, which in turn bolster the medical resources for online healthcare services. The growth of our online healthcare services also broadens user engagement on our platform and enhances overall service utilization, supporting the development of our retail of pharmaceutical and healthcare products. Meanwhile, our wholesale model expands and fortifies our supply chain, which enhances our bargaining power with upstream suppliers and contributes to the diversification of our revenue streams.

Our origins in Shenzhen have laid a solid foundation for our success in this region and its surrounding areas. We have firmly established a notable leadership position within Shenzhen’s digital healthcare integrated service industry, as demonstrated by our robust relationships with local medical and healthcare institutions and professionals. Building upon this success, we have created a digital healthcare and wellness service platform that provides individual users with a wide range of reliable online healthcare services at any time and from anywhere, surpassing the limitations of time and location commonly associated with offline healthcare services. Through our platform, we had extended our service outreach to over 260 cities across China as of March 31, 2025.

We consider the medical resources available on our platform to be the cornerstone of our business. To diversify these resources, we collaborate with well-regarded general and specialty medical and healthcare institutions, as well as highly skilled medical professionals.

Additionally, we strive to expand our coverage of local medical resources to enhance our localized services. To reinforce our medical resources, we have established 11 regional operation centers in key regions such as Shenzhen, Beijing, Shanghai, and Guangzhou. Our geographical footprints in these regions afford customers seamless access to our broad array of product and service offerings and contribute to a thorough healthcare experience for them. The enhanced user recognition in turn attracts new local medical resources to our platform.

Our Business Highlights

As of March 31, 2025, our platform had connected with over 44,600 medical and healthcare institutions cumulatively since our inception, which comprised over 14,400 hospitals (including 3,430 Class III hospitals) and over 30,200 primary healthcare institutions.

As of the same date, among our collaborating medical and healthcare institutions, there were over 6,800 private institutions primarily providing consumer healthcare services on our platform, such as dental, ophthalmology, and physical examination services.

As of the same date, we had established cooperative relationships with over 902,300 medical professionals cumulatively since our inception, which included approximately 46,200 registered physicians. Concurrently, our platform boasts an substantial user base, with 55.2 million registered individual users as of March 31, 2025. In addition, our platform recorded average MAUs of 3.3 million for the three months ended March 31, 2025.

Furthermore, the accumulation of over 5.6 million user reviews underscores the thriving user engagement and dynamic interaction observed on our platform. This multifaceted spectrum of connections and interactions reflects the robustness of our platform’s healthcare service network.



Source: 160 Health (02656) Prospectus (IPO Date : 2025/09/09)
Listing Market MAIN
Industry Health Care Supplies
Background Others
Major Business Area China
Corporate Information
No related information.
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 6 January 2023.